Clover Health Investments, Corp. logo
Clover Health Investments, Corp. CLOV
$ 3.47 -0.57%

Quarterly report 2026-Q1
added 05-08-2026

report update icon

Clover Health Investments, Corp. Income Statement 2011-2026 | CLOV

Annual Income Statement Clover Health Investments, Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.62 B 1.79 B 352 M 538 M 1.12 B 834 M - - - - - - - - -

Shares

512 M 490 M 482 M 476 M 413 M 88.7 M - - - - - - - - -

Historical Prices

3.17 3.65 0.73 1.13 2.72 9.4 - - - - - - - - -

Net Income

-85.5 M -43 M -213 M -339 M -588 M -136 M - - - - - - - - -

Revenue

1.92 B 1.37 B 1.26 B 1.1 B 1.47 B 673 M - - - - - - - - -

Cost of Revenue

225 M 232 M 257 M 279 M 260 M 71.3 M 91.6 M - - - - - - - -

Gross Profit

- - 257 M 22.7 M -79.2 M - - - - - - - - - -

Operating Income

-85.5 M -45.7 M -205 M -287 M -637 M -92.7 M -183 M - - - - - - - -

Interest Expense

- - 7 K 1.33 M 3.19 M 36 M 23.2 M - - - - - - - -

EBITDA

-87.4 M -48.3 M -209 M -288 M -637 M -92.9 M - - - - - - - - -

Operating Expenses

2.01 B 1.42 B 1.47 B 1.38 B 2.11 B 766 M - - - - - - - - -

General and Administrative Expenses

214 M 176 M 183 M 204 M 185 M 121 M - - - - - - - - -

All numbers in USD currency

Quarterly Income Statement Clover Health Investments, Corp.

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

522 M 513 M 509 M 497 M 490 M 487 M 486 M 481 M 479 M 479 M - 478 M 476 M 473 M - 415 M 408 M 376 M - 88.9 M 88.6 M 88.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

27.3 M -24.4 M -10.6 M -1.27 M -9.16 M 7.41 M -19.2 M -41.5 M -28.8 M -72.6 M - -75.5 M -104 M -75.5 M - -34.5 M -318 M -48.4 M - 12.8 M 5.4 M -28.2 M -17.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

749 M 497 M 478 M 462 M 331 M 356 M 347 M 306 M 320 M 322 M - 857 M 847 M 874 M - 427 M 412 M 200 M - 169 M 172 M 166 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

57.1 M 48.2 M 61.3 M 59 M 55 M 55.5 M 59.2 M 60.6 M 62.4 M 69 M - 70.1 M 70.5 M 69.1 M - 73.4 M 62.2 M 66 M - 16.6 M 19.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - 81.2 M 108 M 81.8 M 70.2 M 75.9 M 47.2 M - 17 M -12.1 M 12.7 M - -9.16 M -46 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

27.3 M -24.4 M -10.6 M -1.27 M -8.78 M 7.19 M -22.7 M -33.6 M -28.9 M -79.7 M - -74.1 M -103 M -87.5 M - -149 M -182 M -119 M - -21.6 M 23.2 M -26.6 M -17.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - 7 K - - 404 K 390 K 403 K - 404 K 1.21 M 1.18 M - 9.27 M 8.48 M 7.82 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

26.9 M -24 M -10.2 M -1.71 M -8.45 M 7.52 M -23.4 M -33.1 M -27.9 M -83 M - -73.5 M -102 M -87.5 M - -149 M -182 M -119 M - -21.9 M 22.7 M -27 M -17.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

722 M 521 M 488 M 464 M 340 M 349 M 370 M 340 M 349 M 402 M - 931 M 949 M 962 M - 576 M 594 M 319 M - 191 M 149 M 192 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

74.6 M 49 M 48.5 M 50.7 M 35.2 M 44.4 M 44.6 M 41 M 41.7 M 57.6 M - 47.8 M 47 M 57.7 M - 45.8 M 45.6 M 38.6 M - 29.8 M 21.5 M 28.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Clover Health Investments, Corp. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.